{"pmid":32383171,"title":"Asymptomatic Cases with SARS-CoV-2 Infection.","text":["Asymptomatic Cases with SARS-CoV-2 Infection.","On March 31, 2020, Chinese Health Authorization announced that numbers of asymptomatic cases with SARS-CoV-2 infection will be made to public daily. This was a very important step since different counties have different capacity for detection of SARS-CoV-2 infection and control strategy for COVID-19 outbreak. We summarized the characteristics of asymptomatic SARS-CoV-2 infections and the transmission potential of asymptomatic cases. Then we provided guidelines fo_r the management of asymptomatic cases through quarantine and nucleic acid/serology tests. This article is protected by copyright. All rights reserved.","J Med Virol","Wang, Yishan","Kang, Hanyujie","Liu, Xuefeng","Tong, Zhaohui","32383171"],"abstract":["On March 31, 2020, Chinese Health Authorization announced that numbers of asymptomatic cases with SARS-CoV-2 infection will be made to public daily. This was a very important step since different counties have different capacity for detection of SARS-CoV-2 infection and control strategy for COVID-19 outbreak. We summarized the characteristics of asymptomatic SARS-CoV-2 infections and the transmission potential of asymptomatic cases. Then we provided guidelines fo_r the management of asymptomatic cases through quarantine and nucleic acid/serology tests. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Wang, Yishan","Kang, Hanyujie","Liu, Xuefeng","Tong, Zhaohui"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32383171","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/jmv.25990","keywords":["coronavirus < virus classification","horizontal transmission < epidemiology","respiratory tract < pathogenesis","sars coronavirus < virus classification"],"topics":["Transmission","Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1666267276738822144,"score":9.490897,"similar":[{"pmid":32449789,"title":"Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19.","text":["Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19.","Recurrence of positive SARS CoV-2 PCR has been described in patients discharged from hospital after 2 consecutive negative PCR. We discuss possible explanations including false negative, reactivation and re-infection and propose different strategy to solve this issue. Prolonged SARS-CoV-2 RNA shedding and recurrence of viral RNA shedding in asymptomatic patients remain unknown. Transmission of SARS-CoV-2 by asymptomatic carriers had been documented. Considering the significance of this ongoing global public health emergency, it is necessary to carry out large studies to better understand the issue of potential SARS-CoV-2 recurrence in COVID-19 patients. This article is protected by copyright. All rights reserved.","J Med Virol","Hoang, Van Thuan","Dao, Thi Loi","Gautret, Philippe","32449789"],"abstract":["Recurrence of positive SARS CoV-2 PCR has been described in patients discharged from hospital after 2 consecutive negative PCR. We discuss possible explanations including false negative, reactivation and re-infection and propose different strategy to solve this issue. Prolonged SARS-CoV-2 RNA shedding and recurrence of viral RNA shedding in asymptomatic patients remain unknown. Transmission of SARS-CoV-2 by asymptomatic carriers had been documented. Considering the significance of this ongoing global public health emergency, it is necessary to carry out large studies to better understand the issue of potential SARS-CoV-2 recurrence in COVID-19 patients. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Hoang, Van Thuan","Dao, Thi Loi","Gautret, Philippe"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32449789","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26056","keywords":["coronavirus < virus classification","culture < social science","genetics","sars coronavirus < virus classification"],"topics":["Diagnosis"],"weight":1,"_version_":1667785213888954368,"score":242.38011},{"pmid":32311142,"title":"Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.","text":["Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.","The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved.","J Med Virol","Wu, Xiaodong","Fu, Bo","Chen, Lang","Feng, Yong","32311142"],"abstract":["The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Wu, Xiaodong","Fu, Bo","Chen, Lang","Feng, Yong"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311142","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25904","keywords":["coronavirus < virus classification","humoral immunity < immune responses","inapparent infection < epidemiology"],"locations":["Wuhan","Qingshan Destrict","Wuhan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491155644416,"score":224.78624},{"pmid":32321904,"title":"Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up.","text":["Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up.","Following a containment phase of two months, China has transitioned to the mitigation phase. However, China still faces the risk of COVID-19 spreading due to not only to sporadic new cases and imported cases but also asymptomatic carriers. According to daily reports from the National Health Commission of the People's Republic of China from March 31, 2020 to April 7, 2020, the number of new asymptomatic cases reported daily greatly exceeded that of new imported cases. As of 24:00 on April 7, there were a total of 1,095 asymptomatic cases with COVID-19 under medical observation on the Chinese mainland, including 358 imported cases. A growing number of studies have indicated that asymptomatic carriers are infectious to an extent and can potentially transmit COVID-19. At present, China's measures for managing asymptomatic carriers are 14 days of centralized quarantine and observation; in principle, people with two consecutive negative nucleic acid tests (at an interval of at least 24 hours) can be released from quarantine. However, asymptomatic carriers will not be included in confirmed cases unless they develop clinical manifestations while in quarantine. As \"silent spreaders\", asymptomatic carriers warrant attention as part of disease prevention and control. The testing and follow-up of asymptomatic carriers should be expanded to include people in close contact with patients with confirmed COVID-19 and asymptomatic cases, clusters of outbreaks, and key areas and populations with a high risk of infection.","Biosci Trends","Zhang, Jiao","Wu, Shoucai","Xu, Lingzhong","32321904"],"abstract":["Following a containment phase of two months, China has transitioned to the mitigation phase. However, China still faces the risk of COVID-19 spreading due to not only to sporadic new cases and imported cases but also asymptomatic carriers. According to daily reports from the National Health Commission of the People's Republic of China from March 31, 2020 to April 7, 2020, the number of new asymptomatic cases reported daily greatly exceeded that of new imported cases. As of 24:00 on April 7, there were a total of 1,095 asymptomatic cases with COVID-19 under medical observation on the Chinese mainland, including 358 imported cases. A growing number of studies have indicated that asymptomatic carriers are infectious to an extent and can potentially transmit COVID-19. At present, China's measures for managing asymptomatic carriers are 14 days of centralized quarantine and observation; in principle, people with two consecutive negative nucleic acid tests (at an interval of at least 24 hours) can be released from quarantine. However, asymptomatic carriers will not be included in confirmed cases unless they develop clinical manifestations while in quarantine. As \"silent spreaders\", asymptomatic carriers warrant attention as part of disease prevention and control. The testing and follow-up of asymptomatic carriers should be expanded to include people in close contact with patients with confirmed COVID-19 and asymptomatic cases, clusters of outbreaks, and key areas and populations with a high risk of infection."],"journal":"Biosci Trends","authors":["Zhang, Jiao","Wu, Shoucai","Xu, Lingzhong"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321904","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.5582/bst.2020.03069","keywords":["china","asymptomatic infections","coronavirus disease 2019 (covid-19)"],"locations":["China","China","Chinese","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Prevention","Transmission"],"weight":1,"_version_":1666138493838950400,"score":222.24097},{"pmid":32352576,"title":"COVID-19 in pregnancy: risk of adverse neonatal outcomes.","text":["COVID-19 in pregnancy: risk of adverse neonatal outcomes.","We read with great interest the study by Siyu Chen and colleagues. The authors evaluated the clinical features and outcomes of five pregnant patients with COVID-19 at term, whose delivery was uneventful and led to favorable perinatal outcomes for both mother and neonate. We would like to draw attention to a growing body of evidence that now points towards an under-addressed association between preterm maternal SARS-CoV-2 infection, preterm delivery and adverse neonatal outcomes, which is not reflected in Chen et al.'s small cohort. We also stress that vertical transmission, which was not tested for by Chen et al., should not be excluded as a potential mechanism for viral spread. Centers should therefore be meticulous in their approach to a SARS-CoV-2+ pregnancy to optimize clinical outcomes for both mother and child. This article is protected by copyright. All rights reserved.","J Med Virol","Mehan, Aman","Venkatesh, Ashwin","Girish, Milind","32352576"],"abstract":["We read with great interest the study by Siyu Chen and colleagues. The authors evaluated the clinical features and outcomes of five pregnant patients with COVID-19 at term, whose delivery was uneventful and led to favorable perinatal outcomes for both mother and neonate. We would like to draw attention to a growing body of evidence that now points towards an under-addressed association between preterm maternal SARS-CoV-2 infection, preterm delivery and adverse neonatal outcomes, which is not reflected in Chen et al.'s small cohort. We also stress that vertical transmission, which was not tested for by Chen et al., should not be excluded as a potential mechanism for viral spread. Centers should therefore be meticulous in their approach to a SARS-CoV-2+ pregnancy to optimize clinical outcomes for both mother and child. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Mehan, Aman","Venkatesh, Ashwin","Girish, Milind"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352576","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/jmv.25959","keywords":["coronavirus < virus classification","pandemics < epidemiology","respiratory tract < pathogenesis","vertical transmission < epidemiology"],"topics":["Transmission","Mechanism"],"weight":1,"_version_":1666138495687589891,"score":209.50267},{"pmid":32270882,"title":"False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.","text":["False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.","A novel coronavirus (COVID-19) pandemic cause by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) threatens the world. We read with interest the recent report by Li et al. that included 610 patients with Coronavirus Disease 2019 (COVID-19). They reported a high false-negative rate of real-time reverse transcription polymerase chain reaction (RT-PCR) results for SARS-CoV-2 detection. In addition, recent report regarding SARS-CoV-2 \"turn positive\" in recovered cases with COVID-19 were published. Here, we studied the characteristics of nucleic acid conversion for SARS-CoV-2 from 70 COVID-19 patients. We found that 15 (21.4%) patients experienced a \"turn positive\" of nucleic acid detection by RT-PCR test for SARS-CoV-2 after two consecutive negative results, which may be related to the false negative of RT-PCR test and prolonged nucleic acid conversion This article is protected by copyright. All rights reserved.","J Med Virol","Xiao, Ai Tang","Tong, Yi Xin","Zhang, Sheng","32270882"],"abstract":["A novel coronavirus (COVID-19) pandemic cause by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) threatens the world. We read with interest the recent report by Li et al. that included 610 patients with Coronavirus Disease 2019 (COVID-19). They reported a high false-negative rate of real-time reverse transcription polymerase chain reaction (RT-PCR) results for SARS-CoV-2 detection. In addition, recent report regarding SARS-CoV-2 \"turn positive\" in recovered cases with COVID-19 were published. Here, we studied the characteristics of nucleic acid conversion for SARS-CoV-2 from 70 COVID-19 patients. We found that 15 (21.4%) patients experienced a \"turn positive\" of nucleic acid detection by RT-PCR test for SARS-CoV-2 after two consecutive negative results, which may be related to the false negative of RT-PCR test and prolonged nucleic acid conversion This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Xiao, Ai Tang","Tong, Yi Xin","Zhang, Sheng"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270882","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25855","keywords":["coronavirus < virus classification","sars coronavirus < virus classification","shedding < pathogenesis"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491747041283,"score":203.21185}]}